BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) had its price target boosted by equities researchers at Piper Sandler ...

Research analysts at Piper Sandler assumed coverage on shares of Solaris Energy Infrastructure (NASDAQ:SEI – Get Free Report) ...

Biogen (NASDAQ:BIIB – Get Free Report)‘s stock had its “neutral” rating reiterated by equities research analysts at Piper ...

Denny’s (NASDAQ:DENN – Get Free Report) had its price target lowered by equities researchers at Piper Sandler from $7.00 to ...

Piper Sandler reaffirmed their overweight rating on shares of DraftKings (NASDAQ:DKNG – Free Report) in a research note published on Tuesday morning,Benzinga reports. They currently have a $60. ...

Piper Sandler analyst Matt Farrell adjusted the price target on The Trade Desk (NASDAQ:TTD), a prominent player in the ...

Piper Sandler, a financial services firm, reiterated its Overweight rating on Adobe stock (NASDAQ:ADBE) along with a price ...

Piper Sandler expressed continued confidence in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), maintaining an Overweight ...

Piper Sandler assumed coverage on shares of Compass Therapeutics (NASDAQ:CMPX – Free Report) in a report published on Wednesday morning, MarketBeat.com reports. The firm issued an overweight ...

Piper Sandler analyst Rob Owens increased the price target on Palo Alto Networks (NASDAQ:PANW) stock to $200 from $193, while maintaining a Neutral rating. The adjustment follows Palo Alto Networks' ...

Fintel reports that on February 11, 2025, Piper Sandler downgraded their outlook for Q32 Bio (LSE:0T6G) from Overweight to Neutral. There are 173 funds or institutions reporting positions in Q32 Bio.

Piper Sandler started coverage on shares of enGene (NASDAQ:ENGN – Free Report) in a research report sent to investors on Tuesday morning, MarketBeat.com reports. The brokerage issued an ...